title: Lipidomics study of plasma phospholipid metabolism in early type 2 diabetes rats with ancient prescription Huang-Qi-San intervention by UPLC/Q-TOF-MS and correlation coefficient.
abstract: Potential impact of lipid research has been increasingly realized both in disease treatment and prevention. An effective metabolomics approach based on ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry (UPLC/Q-TOF-MS) along with multivariate statistic analysis has been applied for investigating the dynamic change of plasma phospholipids compositions in early type 2 diabetic rats after the treatment of an ancient prescription of Chinese Medicine Huang-Qi-San. The exported UPLC/Q-TOF-MS data of plasma samples were subjected to SIMCA-P and processed by bioMark, mixOmics, Rcomdr packages with R software. A clear score plots of plasma sample groups, including normal control group (NC), model group (MC), positive medicine control group (Flu) and Huang-Qi-San group (HQS), were achieved by principal-components analysis (PCA), partial least-squares discriminant analysis (PLS-DA) and orthogonal partial least-squares discriminant analysis (OPLS-DA). Biomarkers were screened out using student T test, principal component regression (PCR), partial least-squares regression (PLS) and important variable method (variable influence on projection, VIP). Structures of metabolites were identified and metabolic pathways were deduced by correlation coefficient. The relationship between compounds was explained by the correlation coefficient diagram, and the metabolic differences between similar compounds were illustrated. Based on KEGG database, the biological significances of identified biomarkers were described. The correlation coefficient was firstly applied to identify the structure and deduce the metabolic pathways of phospholipids metabolites, and the study provided a new methodological cue for further understanding the molecular mechanisms of metabolites in the process of regulating Huang-Qi-San for treating early type 2 diabetes.
authors.affiliation: Center Laboratory, Guangdong Pharmaceutical University, Guangzhou 510006, People's Republic of China.
authors.forename: Xia
authors.initials: X
authors.lastname: Wu
authors.affiliation: Center Laboratory, Guangdong Pharmaceutical University, Guangzhou 510006, People's Republic of China.
authors.forename: Jian-Cheng
authors.initials: JC
authors.lastname: Zhu
authors.affiliation: Center Laboratory, Guangdong Pharmaceutical University, Guangzhou 510006, People's Republic of China.
authors.forename: Yu
authors.initials: Y
authors.lastname: Zhang
authors.affiliation: School of Chinese Material Medical, Guangzhou University of Chinese Medicine, Guangzhou 510006, People's Republic of China.
authors.forename: Wei-Min
authors.initials: WM
authors.lastname: Li
authors.affiliation: School of Chinese Material Medical, Guangzhou University of Chinese Medicine, Guangzhou 510006, People's Republic of China.
authors.forename: Xiang-Lu
authors.initials: XL
authors.lastname: Rong
authors.affiliation: Center Laboratory, Guangdong Pharmaceutical University, Guangzhou 510006, People's Republic of China. Electronic address: yffeng@139.com.
authors.forename: Yi-Fan
authors.initials: YF
authors.lastname: Feng
mesh_terms: D000818:Animals; D027885:Astragalus propinquus / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy* / Q000378:metabolism; D004365:Drugs, Chinese Herbal / Q000737:chemistry / Q000627:therapeutic use*; D007004:Hypoglycemic Agents / Q000737:chemistry / Q000627:therapeutic use*; D008297:Male; D013058:Mass Spectrometry / Q000379:methods; D055432:Metabolomics / Q000379:methods; D010743:Phospholipids / Q000097:blood* / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D004365:Drugs, Chinese Herbal; D007004:Hypoglycemic Agents; D010743:Phospholipids; C027492:Huang Qi
keywords: Correlation coefficient; Huang-Qi-San; Multivariate statistic analysis; Phospholipids; Type 2 diabetes; UPLC/Q-TOF-MS